This document discusses different treatment options for benign prostatic hyperplasia (BPH), including:
1) Alpha-blockers which work by blocking alpha-1-adrenoreceptors in the prostate and bladder base, reducing prostate size and improving symptoms but can cause side effects like dizziness and tiredness.
2) 5-alpha-reductase inhibitors like Finasteride which work by blocking the conversion of testosterone to dihydrotestosterone, reducing prostate size over 6 months and improving symptoms but can cause sexual side effects.
3) Combination therapy using both an alpha-blocker and Finasteride has been shown to provide greater reduction in BPH risks than either treatment
This document discusses different treatment options for benign prostatic hyperplasia (BPH), including:
1) Alpha-blockers which work by blocking alpha-1-adrenoreceptors in the prostate and bladder base, reducing prostate size and improving symptoms but can cause side effects like dizziness and tiredness.
2) 5-alpha-reductase inhibitors like Finasteride which work by blocking the conversion of testosterone to dihydrotestosterone, reducing prostate size over 6 months and improving symptoms but can cause sexual side effects.
3) Combination therapy using both an alpha-blocker and Finasteride has been shown to provide greater reduction in BPH risks than either treatment
This document discusses different treatment options for benign prostatic hyperplasia (BPH), including:
1) Alpha-blockers which work by blocking alpha-1-adrenoreceptors in the prostate and bladder base, reducing prostate size and improving symptoms but can cause side effects like dizziness and tiredness.
2) 5-alpha-reductase inhibitors like Finasteride which work by blocking the conversion of testosterone to dihydrotestosterone, reducing prostate size over 6 months and improving symptoms but can cause sexual side effects.
3) Combination therapy using both an alpha-blocker and Finasteride has been shown to provide greater reduction in BPH risks than either treatment
alpha-1-adrenoreceptors, and the prostate shows a contractile response to corresponding agonists.
At higher doses, little additional symptomatic
improvement is observed and sideeffect profiles worsen. Typical side effects include orthostatic hypotension, dizziness, tiredness, retrograde ejaculation, rhinitis, and headache. 5-ALPHA-REDUCTASE INHIBITORS
Finasteride is a 5- alpha-reductase inhibitor that blocks
the conversion of testosterone to dihydrotestosterone. This drug affects the epithelial component of the prostate, resulting in a reduction in the size of the gland and improvement in symptoms. Six months of therapy are required to see the maximum effects on prostate size (20% reduction) and symptomatic improvement.
Side effects include decreased libido,decreased
ejaculate volume, and impotence. Serum PSA is reduced by approximately 50% in patients being treated with finasteride, FARMAKOKINETIK FINASTERID
Penyerapan dan distribusi: Setelah pemberian oral
finasteride cepat diserap dari saluran pencernaan. Bioavailabilitas sekitar 80% dan independen dari asupan makanan Konsentrasi plasma maksimum dicapai dalam 1-2 jam setelah pemberian oral. Protein plasma mengikat tentang 90%. Metabolisme dan ekskresi: Finasteride dimetabolisme oleh hati dan diekskresikan sebagai metabolit dalam urin dan feses. COMBINATION THERAPY
study investigating combination alpha-blocker and
5-alpha-reductase inhibitor therapy
Over 1200 patients participated, and significant
decreases in symptom score and increases in urinary flow rates were.
The reduction in risk associated with combination
therapy (66% risk reduction) was significantly greater than that associated with doxazosin or finasteride alone PHYTOTHERAPY
Phytotherapy refers to the use of plants or plant
extracts for medicinal purposes. The use of phytotherapy in BPH has been popular in Europe for years, Several plant extracts have been popularized, including the saw palmetto berry, (Serenoa repens) the bark of Pygeum africanum, the roots of Echinacea purpurea and Hypoxis rooperi, pollen extract randomized clinical trial of saw palmetto showed no benefit beyond placebo for symptom improvement or urinary flow rate